UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy

Blood coagulation & fibrinolysis, 2014-07, Vol.25 (5), p.444-450

2014

Volltextzugriff (PDF)

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

Thrombosis and haemostasis, 2008-03, Vol.99 (3), p.616-622

2008

Volltextzugriff (PDF)

Pharmacokinetics of Recombinant Human Antithrombin in Delivery and Surgery Patients With Hereditary Antithrombin Deficiency

Clinical and applied thrombosis/hemostasis, 2014-05, Vol.20 (4), p.355-364

2014

Volltextzugriff (PDF)

Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro , on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0227321-e0227321

2022

Volltextzugriff (PDF)

Selective Depletion of Staphylococcus aureus Restores the Skin Microbiome and Accelerates Tissue Repair after Injury

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.1865-1876.e3

2024

Volltextzugriff (PDF)

Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma

Journal of investigative dermatology, 2023-09, Vol.143 (9), p.1757-1768.e3

2023

Volltextzugriff (PDF)

Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis

Journal of drugs in dermatology, 2021-12, Vol.20 (12), p.1323-1328

2021

Volltextzugriff (PDF)

Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis

Thrombosis research, 2014-06, Vol.133 (6), p.972-984

2014

Volltextzugriff (PDF)

Dose Selection of Antithrombin (Recombinant) for a Phase 3 Trial in Early-Onset Preeclampsia [149]

Obstetrics and gynecology (New York. 1953), 2015-05, Vol.125 (Supplement 1), p.52

2015

Volltextzugriff (PDF)

Circulating interleukin-6 receptor in patients with sepsis syndrome

The Journal of infectious diseases, 1995-02, Vol.171 (2), p.469-472

1995

Volltextzugriff (PDF)

Spatial Resolution in Digital Mammography

Investigative radiology, 1993-05, Vol.28 (5), p.413-419

1993

Volltextzugriff (PDF)

Plasma Patterns of Tumor Necrosis Factor-α (TNF) and TNF Soluble Receptors During Acute Meningococcal Infections and the Effect of Plasma Exchange

Clinical infectious diseases, 1998-04, Vol.26 (4), p.918-923

1998

Volltextzugriff (PDF)

Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data

American journal of perinatology, 2016-03, Vol.33 (4), p.343-349

2016

Volltextzugriff (PDF)

Exploring the Role of Antithrombin Replacement for the Treatment of Preeclampsia: A Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Preeclampsia (PRESERVE-1)

American journal of reproductive immunology (1989), 2013-06, Vol.69 (6), p.539-544

2013

Volltextzugriff (PDF)

Interleukin-6 and its soluble receptor during acute meningococcal infections: Effect of plasma or whole blood exchange

Critical care medicine, 1996-11, Vol.24 (11), p.1801-1805

1996

Volltextzugriff (PDF)

Antithrombin Alfa in Hereditary Antithrombin Deficient Patients at High Risk for Thromboembolic Complications

Blood, 2008-11, Vol.112 (11), p.986-986

2008

Volltextzugriff (PDF)

Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy

American journal of nephrology, 1999, Vol.19 (5), p.571-575

1999

Volltextzugriff (PDF)

No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies

Blood, 2007-11, Vol.110 (11), p.3197-3197

2007

Volltextzugriff (PDF)

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations

Blood, 2004-11, Vol.104 (11), p.4076-4076

2004

Volltextzugriff (PDF)

Soluble interleukin 6 receptor in biological fluids from human origin

Cytokine (Philadelphia, Pa.), 1994-07, Vol.6 (4), p.376-381

1994

Volltextzugriff (PDF)

Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in renal replacement theraphy

American journal of nephrology, 1999-09, Vol.19 (5), p.571

1999

Volltextzugriff (PDF)

Circulating Concentrations of Soluble Interleukin 6 Receptors gp80 and gp130 in Chronic Renal Failure and Effects ofRenal Replacement Therapy

American journal of nephrology, 1999-05, Vol.19 (5), p.571-575

1999

Volltextzugriff (PDF)

Soluble interleukin-6 receptor in patients with severe sepsis

The Journal of infectious diseases, 1995-08, Vol.172 (2), p.607-607

1995

Volltextzugriff (PDF)

S3-Leitlinie Divertikelkrankheit/Divertikulitis – Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV): November 2021 – AWMF-Registernummer: 021-20

Zeitschrift für Gastroenterologie, 2022-04, Vol.60 (4), p.613-688

2022

Volltextzugriff (PDF)

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

Pediatric nephrology (Berlin, West), 2014-10, Vol.29 (10), p.1967-1978

2014

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)

Sprache

Englisch
(25)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(17)
Female
(13)
Adult
(9)
Male
(9)
Middle Aged
(7)
Adolescent
(5)
Hematology
(5)
Immunology
(5)
Biological And Medical Sciences
(4)
Child
(4)
Cytokines
(4)
Infectious Diseases
(4)
Medical Sciences
(4)
Microbiology
(4)
Prospective Studies
(4)
Receptors, Interleukin-6
(4)
Aged
(3)
Anticoagulants - Administration & Dosage
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

Pharmacokinetics of Recombinant Human Antithrombin in Delivery and Surgery Patients With Hereditary Antithrombin Deficiency

Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro , on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection

Selective Depletion of Staphylococcus aureus Restores the Skin Microbiome and Accelerates Tissue Repair after Injury

Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma

Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis

Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis

Dose Selection of Antithrombin (Recombinant) for a Phase 3 Trial in Early-Onset Preeclampsia [149]

Circulating interleukin-6 receptor in patients with sepsis syndrome

Spatial Resolution in Digital Mammography

Plasma Patterns of Tumor Necrosis Factor-α (TNF) and TNF Soluble Receptors During Acute Meningococcal Infections and the Effect of Plasma Exchange

Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data

Exploring the Role of Antithrombin Replacement for the Treatment of Preeclampsia: A Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Preeclampsia (PRESERVE-1)

Interleukin-6 and its soluble receptor during acute meningococcal infections: Effect of plasma or whole blood exchange

Antithrombin Alfa in Hereditary Antithrombin Deficient Patients at High Risk for Thromboembolic Complications

Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy

No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations

Soluble interleukin 6 receptor in biological fluids from human origin

Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in renal replacement theraphy

Circulating Concentrations of Soluble Interleukin 6 Receptors gp80 and gp130 in Chronic Renal Failure and Effects ofRenal Replacement Therapy

Soluble interleukin-6 receptor in patients with severe sepsis

S3-Leitlinie Divertikelkrankheit/Divertikulitis – Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV): November 2021 – AWMF-Registernummer: 021-20

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

Suchergebnisse filtern